focus -WSS

focus

author：focus 2025-09-28 00:49:54 - browse：14

Adobe

WASHINGTON — The federal government increasingly is scrutinizing Chinese businesses and their interactions with American companies, including in the biotech sector. Chinese biotechnology companies, the thinking goes, could threaten national security by giving the Chinese government access to the genetic and health information of Americans.

Just Wednesday, President Biden issued an executive order aimed at keeping sensitive data, including Americans’ genetic information, out of the hands of adversaries.

But American biotech companies worry they could become collateral damage if the government sloppily targets sanctions. They’re pushing back against legislation that would bar biotech companies from working with some Chinese companies, especially as the government takes aim at WuXi, a Chinese company considered a crucial partner for discovering, testing, and making medicines that has worked with such brands as Pfizer, AstraZeneca, and GSK.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Just how do doctors, lawmakers, and the public define abortion?

focus

WSS

Listen: Who gets the credit for GLP

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Ionis has late

Health tech startups drop sharply from 2021 highs

FDA advisers vote against ALS treatment from BrainStorm

Precocious puberty in girls comes with mental health risks

leisure time

focus

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Address the ethical violations that led to 'Three Identical Strangers'

Jerome Adams on the need for new antivirals for Covid

Amylyx ALS drug fails large clinical trial

Virginia high school admissions case could be legal follow

Did you have Obamacare on your GOP debate bingo card?

How one medical school became remarkably diverse

Researchers use wearables data and AI to predict preterm birth risk

As demand for Covid shots wanes, Moderna seeks its next success

Cigna to pay $172 million to settle Medicare Advantage fraud probe

focus

Headspace, Meta partner to launch VR meditation app for Quest

Address the ethical violations that led to 'Three Identical Strangers'

After a drawn out lobbying fight, ARPA

Shingles, which affected Dianne Feinstein, is on the rise

The drug industry has found itself all alone in Washington

Paxlovid should be available without a positive Covid test

focus

knowledge

leisure time

Wikipedia